Forbes

This week’s edition of InnovationRx looks at Vitestro’s newly authorized robot, Italy’s $10 billion pharma family, this year’s Covid-19 vaccines and more.

Since USPSTF recommendations guide insurer decisions on what types of preventive care to fully cover, the panel's ongoing upheaval may lead to coverage limits.

Forward-deployed engineers are spreading across healthcare, changing how software is built and resurfacing old tensions between customization and scale.

A new molecular glue reprograms the lymphoma protein BCL6 to switch cancer-cell death back on, clearing aggressive tumors in mice in just 11 days.

The Trump administration has mostly shut down the Agency for Healthcare Research and Quality, which has been key in raising awareness and improving patient safety.

A Stanford study's 12-month follow-up reveals significant improvements in PTSD, depression, and anxiety in Special Operations veterans with TBIs after ibogaine treatment.

A public health researcher raises concerns that the rise of e-scooters and e-bikes might be inadvertently engineering physical activity out of daily life.

Bank of America is bucking the downward trend in employer-sponsored coverage of GLP-1s for weight loss by maintaining its comparatively generous policies.

President Trump vowed better access to GLP-1 weight loss drugs for Medicaid recipients. But thus far only Indiana has publicly signed on with the administration’s demo.

Measles cases in the U.S. have topped 2,700 in 2026. Here's what to know about immunity, exposure windows, and where to get care safely.

Inside Hundred Health’s app, biomarker results shape nutrition, supplements, fitness and recovery—recommendations guests can follow at Santa Monica Proper.